Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DR26FGJ7W
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,563
Award facts
- Contract value 100% obligated
- $14,562.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Dupixent 300 mg/2 ml pen injectors with a contract value of $14,562.52. This competitively awarded, non-set-aside delivery order is scheduled for completion by November 17, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Dupixent is a biologic medication used to treat conditions including atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyposis, making this procurement consistent with the Defense Health Agency's pharmaceutical supply requirements.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime vendor contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. As one of the largest pharmaceutical distributors in the federal sector, AmerisourceBergen maintains an extensive portfolio of delivery orders covering multiple therapeutic domains and fulfills critical medical supply needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FGJ7W?
SPE2DR26FGJ7W was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 14, 2025.
How much is contract SPE2DR26FGJ7W worth?
The government has obligated $14,563 on SPE2DR26FGJ7W.
Is contract SPE2DR26FGJ7W an order under another contract?
Yes. SPE2DR26FGJ7W is a delivery order under SPE2DR25D1002, an indefinite delivery contract.
Was contract SPE2DR26FGJ7W competed?
The extent of competition for SPE2DR26FGJ7W was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award